Delving into the Latest Updates on Hebei Dongfeng Pharmaceutical Co. Ltd. with Synapse

Overview

Basic Info

Introduction

Hebei Dongfeng Pharmaceutical Co., Ltd. stands as a highly respected and modernized large-scale pharmaceutical manufacturer within China's domestic market. For many years, the firm has maintained a leading market position both domestically and internationally, thanks to its strict adherence to GMP protocols, consistent product quality, and comprehensive marketing services.

Tags

Digestive System Disorders

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

No Data

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

mAChRs(Muscarinic acetylcholine receptor)	1

[Translation] A single-center, randomized, open-label, single-dose, two-period, double-crossover bioequivalence study of enalapril maleate tablets produced by Hebei Dongfeng Pharmaceutical Co., Ltd. and enalapril maleate tablets (trade name: Renitec®) produced by Merck Sharp & Dohme B.V. in healthy Chinese subjects under fasting and fed conditions

以河北东风药业有限公司生产的马来酸依那普利片（规格：10 mg）为受试制剂，Merck Sharp & Dohme B.V.生产的马来酸依那普利片（商品名：Renitec®，规格10mg）为参比制剂，考察两制剂在空腹及餐后状态下单次给药的药代动力学参数及相对生物利用度，评价两制剂是否具有生物等效性；同时评价两种制剂在健康人体中的安全性和耐受性。

[Translation]

Enalapril Maleate Tablets (Specification: 10 mg) produced by Hebei Dongfeng Pharmaceutical Co., Ltd. was used as the test preparation, and Enalapril Maleate Tablets (Trade Name: Renitec®, Specification: 10 mg) produced by Merck Sharp & Dohme B.V. was used as the reference preparation. The pharmacokinetic parameters and relative bioavailability of the two preparations after single administration in the fasting and postprandial states were investigated to evaluate whether the two preparations were bioequivalent; at the same time, the safety and tolerability of the two preparations in healthy humans were evaluated.

Start Date16 Sep 2023

Sponsor / Collaborator

Hebei Dongfeng Pharmaceutical Co. Ltd.

100 Clinical Results associated with Hebei Dongfeng Pharmaceutical Co. Ltd.

Login to view more data

0 Patents (Medical) associated with Hebei Dongfeng Pharmaceutical Co. Ltd.

Login to view more data

100 Deals associated with Hebei Dongfeng Pharmaceutical Co. Ltd.

Login to view more data

100 Translational Medicine associated with Hebei Dongfeng Pharmaceutical Co. Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 25 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

1

Login to view more data